Search
Refine your search
62 results found
Lexology PRO | Australia, Canada, European Union, etc. | 25 Feb 2021
Five golden rules for a strong fraud prevention programme
Omri Kletter, Global Vice President of cyber-fraud and risk management at Bottomline, shares his five golden rules for strengthening a fraud prevention programme.Bottomline is an online payment security software provider, based in the UK.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Canada, European Union, etc. | 25 Feb 2021
How to defend against cyber-fraud
Omri Kletter, Global Vice President of cyber-fraud and risk management at Bottomline, sets out the best ways businesses can defend their systems against cyber-fraud.Bottomline is an online payment security software provider, based in the UK.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Canada, European Union, etc. | 25 Feb 2021
Cyber-fraud: Identifying and preventing risk
Omri Kletter, Global Vice President of cyber-fraud and risk management at Bottomline, outlines the most dangerous forms of cyber-fraud, and how to guard against them.Bottomline is an online payment security software provider, based in the UK.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
How compliance games boost business engagement
Rafael Ferri, legal director at Novartis (Brazil), looks back at his experiments with gamification to boost compliance-business engagement while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
How to increase business-compliance engagement
Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices to boost compliance-business engagement that he used while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
Business-compliance engagement: What is coming in 2021?
Rafael Ferri, legal director at Novartis (Brazil), highlights up-coming trends and areas to watch relating to compliance-business engagement in 2021.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
How to facilitate business-compliance engagement during COVID-19
Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices he used to boost compliance-business engagement during the COVID-19 pandemic in his role as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Canada, European Union, etc. | 1 Feb 2021
COVID-19: Top tips for conducting a virtual internal investigation
Fabiana Lacerca-Allen, Senior Vice President of compliance at Aimmune Therapeutics, shares her top tips on how to conduct a successful virtual internal investigation during the COVID-19 pandemic.Aimmune Therapeutics is a Nestle Health Science company, based in California, US.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Canada, European Union, etc. | 1 Feb 2021
What makes a successful internal investigation?
Fabiana Lacerca-Allen, Senior Vice President of compliance at Aimmune Therapeutics, discusses the key considerations and best practices to conduct a successful internal investigation.Aimmune Therapeutics is a Nestle Health Science company, based in California, US.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology PRO | Australia, Canada, European Union, etc. | 1 Feb 2021
Top tips for conducting an internal investigation
Fabiana Lacerca-Allen, Senior Vice President of compliance at Aimmune Therapeutics, shares her top tips on how to conduct a successful internal investigation.Aimmune Therapeutics is a Nestle Health Science company, based in California, US.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
